TRVI Trevi Therapeutics, Inc.
Healthcare$14.33+0.00%OpenMarket Cap: $2.03B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$25.00
Target (Median)
$25.00
Target Range
$20.00 - $30.00
Upside from current price: 74.4%
Rating Distribution
2 Strong Buy9 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-20 | Needham | maintain | Buy | Buy |
| 2026-05-06 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-04-17 | D. Boral Capital | maintain | Buy | Buy |
| 2026-03-19 | Jones Trading | maintain | Buy | Buy |
| 2026-03-18 | Needham | maintain | Buy | Buy |
| 2026-03-18 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-03-09 | D. Boral Capital | maintain | Buy | Buy |
| 2026-03-09 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-01-09 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-01-08 | D. Boral Capital | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.59 | $3.5M | 8 |
| Sun Dec 31 | $-0.70 | $31.9M | 8 |
| Mon Dec 31 | $-0.69 | $58.3M | 6 |
| Tue Dec 31 | $-0.10 | $213.1M | 6 |